Dr Reddys Laboratories (DRL): Dr Reddys aims for sustainable dual-digit top-line development. It also plans to expand its existing business and look for new opportunities such as Biologics CDMO & CGT. The stock has a target price of Rs 5,036 per share.
DCB Bank: Although primarily operating in the self-employed segment, DCB has been able to manage asset quality pressure well. Thus the collection is good. While this is likely to continue, Axis Securities said in a statement that the security of the bank’s restructured book indicates that borrowing costs are moving forward.
Due to this, it has recommended a buy price of Rs 115 per share. This represents an increase of over 50% from the current stock level.
L&T Foods: Geojit brokerage firm says the LDF’s ongoing efforts to strengthen its brand, expand its distribution network, and diversify its region and products through organic and mineral channels.
Recent acquisitions in the Jasmine rice segment will strengthen market share. Reopening HoReCa channels will help in its development. At the same time LTF’s strong focus on value-added products will improve margins. Also, its LDF is currently trading at 7x 1Yr Fwd P / E. The value of L&T Foods shares has increased. Its current margin price is Rs.